EU and US could reach trade deal this weekend - Reuters
Shelagh Glaser, Chief Financial Officer of Synopsys Inc . (NASDAQ:SNPS), a prominent software company with a market capitalization of $77.5 billion and impressive gross profit margins of 81%, executed significant stock transactions on June 6, 2025, according to a recent SEC filing. According to InvestingPro analysis, the company currently trades at a premium valuation with a P/E ratio of 57. Glaser sold a total of 7,310 shares of Synopsys common stock at an average price of $485.72 per share, totaling approximately $3.55 million. The sales were part of a pre-arranged trading plan under Rule 10b5-1, which was adopted on January 13, 2025. The company maintains strong financial health with a "GOOD" rating from InvestingPro, which has identified 14 additional key insights about the company’s performance and outlook.
In addition to the sales, Glaser exercised options to acquire 7,310 shares of Synopsys stock. The exercise prices ranged from $348.17 to $354.45 per share, with the total value of these transactions amounting to approximately $2.56 million. After these transactions, Glaser holds 15,291 shares directly. The company demonstrates robust liquidity with a current ratio of 7.02, indicating strong financial flexibility.
In other recent news, Synopsys has suspended its financial guidance for the third quarter and the full fiscal year of 2025 following new export restrictions related to China. Prior to this suspension, Synopsys had projected third-quarter revenue between $1.755 billion and $1.785 billion, with non-GAAP earnings per share ranging from $3.82 to $3.87. The company had also reaffirmed its full-year 2025 revenue guidance of $6.745 billion to $6.805 billion. This development comes after Synopsys reported second-quarter results with adjusted earnings per share of $3.67, exceeding analyst estimates of $3.39, and revenue of $1.604 billion, slightly above expectations.
Despite the uncertainties, Stifel analysts have maintained a Buy rating with a $550 price target for Synopsys, citing confidence in the company’s core business. Similarly, KeyBanc Capital Markets reiterated an Overweight rating with a $575 price target, acknowledging potential risks in China but expressing optimism about Synopsys’s growth in other regions and sectors. BofA Securities also lifted its price target to $575, maintaining a Buy rating, while noting a decline in Synopsys’s China sales. Synopsys remains on track to finalize its acquisition of Ansys (NASDAQ:ANSS) by mid-2025, although discussions in China are ongoing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.